Vaccines

There is consensus among the global health community that long-term collaboration in resilient biomanufacturing capacity and supply chains…

recently commissioned Economist Intelligence Clearstate, a division of The Economist, to conduct a study on the future of…

The biopharmaceutical industry trends towards new product classes and smaller batch sizes drives even a greater need for…

Join us for this panel discussion to discover how a large global network of scientific experts, innovative technologies, and non-GMP facilities empower startups to advance scientific innovation through collaborative exploration and learning.

We invite you to the 4th Annual Biotech Start-up Symposium, a free, two-day event to help Biotech Start-ups navigate their path to commercialization. 

Traditional scale-down models lack true perfusion capabilities, therefore not optimum for the perfusion media development process. Mobius® Breez microbioreactors with true perfusion capability are highly predictable to larger scale bioreactors, thus significantly enhancing our current workflow.

Single-use technologies are well-suited for the manufacture of mRNA. Not only do they offer increased flexibility, they can…

The Chemical Engineering magazine has published its third article of the biopharmaceutical manufacturing series, written by David Gemmell….

This webinar describes the collaboration of

, and G-CON to develop a proof-of-concept facility design that enables multi-modal bioprocessing with greater flexibility and agility which facilitates tech transfer and future expansion.

Chemical Engineering Magazine has published its second article of the biopharmaceutical manufacturing series, written by Biomanufacturing Engineer, David…